When doctors discuss prognosis with advanced cancer patients, those patients have more realistic views of their life expectancy and don’t seem to experience a decrease in emotional wellbeing, according to Holly Prigerson. Read more
A team led by Olivier Elemento, Ph.D., is the first to demonstrate an epigenetic role for the activation-induced cytidine deaminase (AID) gene. Read more
Vivek Mittal and others from Weill Cornell and Houston Methodist and Weill Cornell received a multi-million dollar grant to support their tumor microenviroment and crosstalk studies. Read more
Claudia Fischbach-Teschl, Ph.D., pens a guest post about the importance of targeting the tumor microenvironment in cancer research and therapy. Read more
A team led by Ari Melnick, M.D., has found that a genetic mutation implicated in a common and incurable form of non-Hodgkin lymphoma drives disease development by disrupting the mechanism that manages normal immune cell growth. Read more
Ashish Saxena, M.D., Ph.D., comments on a study that found nivolumab offers better outcomes than docetaxel for patients with advanced squamous-cell non-small cell lung cancer. Read more
Watchful waiting or active treatment? Jim Hu, M.D., has studied surveillance strategies among patients diagnosed with localized prostate cancer. Read more